These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 3033215)

  • 1. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain.
    Balduini W; Murphy SD; Costa LG
    J Pharmacol Exp Ther; 1987 May; 241(2):421-7. PubMed ID: 3033215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbachol- and norepinephrine-stimulated phosphoinositide metabolism in rat brain: effect of chronic cholinesterase inhibition.
    Costa LG; Kaylor G; Murphy SD
    J Pharmacol Exp Ther; 1986 Oct; 239(1):32-7. PubMed ID: 3020234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ethanol on muscarinic receptor-stimulated phosphoinositide metabolism during brain development.
    Balduini W; Costa LG
    J Pharmacol Exp Ther; 1989 Aug; 250(2):541-7. PubMed ID: 2547937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cholinergic muscarinic receptor-stimulated phosphoinositide metabolism in brain from immature rats.
    Balduini W; Murphy SD; Costa LG
    J Pharmacol Exp Ther; 1990 May; 253(2):573-9. PubMed ID: 2160000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental neurotoxicity of ethanol: in vitro inhibition of muscarinic receptor-stimulated phosphoinositide metabolism in brain from neonatal but not adult rats.
    Balduini W; Costa LG
    Brain Res; 1990 Apr; 512(2):248-52. PubMed ID: 2162233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of cortical muscarinic receptor subtypes and muscarinic receptor-mediated responses in rat.
    Lee W; Nicklaus KJ; Manning DR; Wolfe BB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):482-90. PubMed ID: 2156047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine-stimulated phosphoinositide hydrolysis in developing rat brain.
    Claro E; García A; Picatoste F
    Mol Pharmacol; 1987 Sep; 32(3):384-90. PubMed ID: 2823091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW; Wolfe BB
    J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of short chain aliphatic alcohols with muscarinic receptor-stimulated phosphoinositide metabolism in cerebral cortex from neonatal and adult rats.
    Candura SM; Balduini W; Costa LG
    Neurotoxicology; 1991; 12(1):23-32. PubMed ID: 1849621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
    Lee W; Wolfe BB
    Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitter-specific profiles of inositol phosphates in rat brain cortex: relation to the mode of receptor activation of phosphoinositide phospholipase C.
    Sarri E; Picatoste F; Claro E
    J Pharmacol Exp Ther; 1995 Jan; 272(1):77-84. PubMed ID: 7815367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
    McKinney M; Anderson D; Vella-Rountree L
    Mol Pharmacol; 1989 Jan; 35(1):39-47. PubMed ID: 2536467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium ions potentiate the muscarinic receptor-stimulated phosphoinositide metabolism in cerebral cortex slices: a comparison of neonatal and adult rats.
    Balduini W; Costa LG; Murphy SD
    Neurochem Res; 1990 Jan; 15(1):33-9. PubMed ID: 2157990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.
    Fisher SK; Snider RM
    Mol Pharmacol; 1987 Jul; 32(1):81-90. PubMed ID: 3600615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of muscarinic receptor- and G-protein-dependent phosphoinositide metabolism in cerebrocortical membranes from neonatal rats by ethanol.
    Candura SM; Manzo L; Costa LG
    Neurotoxicology; 1992; 13(1):281-8. PubMed ID: 1324450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal ontogeny of agonist and depolarization-induced phosphoinositide hydrolysis in rat cerebral cortex.
    Rooney TA; Nahorski SR
    J Pharmacol Exp Ther; 1987 Oct; 243(1):333-41. PubMed ID: 2822903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothyroidism inhibits the formation of inositol phosphate in response to carbachol in the striatum of adult rat.
    Iriuchijima T; Michimata T; Mizuma H; Murakami M; Yamada M; Mori M
    Res Commun Chem Pathol Pharmacol; 1991 Aug; 73(2):173-80. PubMed ID: 1784833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.